Generated July 13, 2026 at 8:34 PM ET
· Covers July 13 trading day
· 10 of 140 ready 8-Ks selected
· AI-assisted overview
The day's highest-materiality filings featured multiple Nasdaq delistings, with BNB Plus (BNBX) and Actelis Networks (ASNS) moving to OTCQB, and Pluri (PLUR) receiving a non-compliance notice. In M&A, Matinas BioPharma (MTNB) agreed to combine with GH Power and sold its Nano business, while Edgewise Therapeutics (EWTX) completed the sale of its muscular dystrophy program to Servier for up to $2.65B, and First Hawaiian (FHB) announced an all-stock acquisition of TriCo Bancshares. Other notable events included Trex (TREX) realigning its distribution network and raising its FY26 outlook, Chesapeake Utilities (CPK) unveiling a $1.2B Florida pipeline project, and Agenus (AGEN) raising $85M upfront to fund a Phase 3 colon cancer trial.
regulatory
negative
materiality 0.90
July 13, 2026, 8:05 AM ET
BNB Plus receives Nasdaq delisting notice; shares to move to OTCQB on July 14
- Nasdaq Hearing Panel determined to delist BNBX common stock for failure to maintain $1.00 bid price per Rule 5550(a)(2).
- Trading suspended at open on July 14, 2026; shares to begin trading on OTCQB under same symbol BNBX.
- Company will request Listing Council Review, but no stay of delisting; no assurance of reversal or relisting.
MTNB
Matinas BioPharma Holdings, Inc.
M&A
negative
materiality 0.90
July 13, 2026, 8:05 AM ET
Matinas BioPharma to combine with GH Power; MTNB holders get 9% of combined co; sells Nano to Azurity
- Business Combination Agreement with GH Power: MTNB shareholders receive 0.1 Pubco share per MTNB share; GH Power holders get ~91% of combined entity.
- Stock Purchase Agreement: Matinas Nano sold to Azurity for up to $21.5M cash ($4M upfront, $17.5M milestones) plus mid-single-digit royalty on MAT2203.
- Series D PIPE closed: $575,000 gross proceeds from sale of convertible preferred stock and warrants; requires stockholder approval for conversion shares.
EWTX
Edgewise Therapeutics, Inc.
M&A
positive
materiality 0.90
July 13, 2026, 8:37 AM ET
Edgewise completes $1.55B sale of muscular dystrophy program to Servier; up to $2.65B total
- Sold sevasemten and muscular dystrophy program to Servier for $1.55B upfront plus up to $1.1B in milestones ($2.65B total).
- Company refocuses on cardiovascular pipeline: EDG-7500 (HCM), EDG-15400 (HFpEF), and EDG-003 (undisclosed).
- Upfront proceeds expected to fully fund EDG-7500 development through potential approval.
M&A
positive
materiality 0.90
July 13, 2026, 7:15 AM ET
First Hawaiian to acquire TriCo Bancshares in $63.12/share all-stock deal; Q2 prelim EPS $0.60
- First Hawaiian to acquire TriCo Bancshares in all-stock transaction valued at $63.12 per TriCo share (2.095 FHB shares per TCBK share).
- Combined company to have ~$34B in assets, becoming 6th largest bank headquartered in Western U.S.; FHB shareholders to own ~65%.
- No branch closings expected; four TriCo directors to join FHB board; deal expected to close by end of 2026.
ASNS
ACTELIS NETWORKS INC
regulatory
negative
materiality 0.85
July 13, 2026, 5:00 PM ET
Actelis Networks to be officially delisted from Nasdaq; stock trades on OTCQB
- Nasdaq issued press release on July 10, 2026, stating official delisting and filing of Form 25-NSE.
- Delisting will become effective ten days after the Form 25-NSE is filed.
- Company's common stock has been suspended from trading on Nasdaq since April 10, 2026.
regulatory
negative
materiality 0.75
July 13, 2026, 4:05 PM ET
Pluri receives Nasdaq delisting notice for failing MVLS minimum of $35M
- Received Nasdaq notice on July 7, 2026 for non-compliance with MVLS minimum of $35M.
- Also fails alternative standards: stockholders' equity < $2.5M or net income < $500K.
- Has 180 days until January 4, 2027 to regain compliance by closing MVLS at $35M+ for 10 consecutive days.
debt
positive
materiality 0.65
July 13, 2026, 4:10 PM ET
Realty Income expands revolving credit facilities to $5.5B and commercial paper programs to $5.5B
- Revolving credit facilities upsized from $4.0B to $5.5B, with accordion to $6.5B; two tranches mature 2029 and 2030.
- All-in drawn pricing reduced by 5 bps to 80 bps over SOFR, based on A3/A- ratings.
- Global commercial paper programs expanded to $5.5B combined ($2.75B US, $2.75B Euro).
other material
positive
materiality 0.85
July 13, 2026, 4:07 PM ET
Trex realigns distribution network; SBP sole national distributor; Q2 rev ~$418M above guidance, raises FY26 outlook
- Q2 preliminary revenue ~$418M (above guidance $388-403M); adjusted EBITDA ~$112M; full year 2026 guidance raised.
- SBP (Specialty Building Products) named sole national distributor of Trex products in North America, effective Jan 1, 2027.
- Terminates distribution relationship with Boise Cascade effective Aug 12, 2026; no termination fees.
CPK
CHESAPEAKE UTILITIES CORP
other material
positive
materiality 0.85
July 13, 2026, 11:45 AM ET
Chesapeake Utilities announces $1.2B Florida Energy Pathway natural gas pipeline project
- 24-inch intrastate pipeline from Palm Beach to Miami-Dade County; in-service target 2030.
- Firm commitments for ~250,000 dekatherms/day from multiple investment-grade shippers.
- Company plans to partner with third parties for up to 49% project ownership.
other material
positive
materiality 0.85
July 13, 2026, 6:30 AM ET
Agenus raises $85M upfront (up to $340M) to fund registrational Phase 3 ROBBIN trial of BOT+BAL in MSS colon cancer
- Private placement of $85M upfront gross proceeds, plus up to $255M from warrant exercise; total up to $340M.
- Proceeds to fund ROBBIN Phase 3 trial in neoadjuvant MSS colon cancer; expected runway through year-end 2031 if warrants exercised.
- ROBBIN trial to enroll 850 patients, primary endpoint EFS; first patient dosed Q1 2027, interim pathologic response data H2 2027.